{"api":"v1","generated_at":"2026-10-01T10:19:03.955Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-promise-0eae4f","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-promise-0eae4f/at/2026-10-01T05-50Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-01T05:50:06.230Z","snapshot_stamp":"2026-10-01T05-50Z","endpoint":{"slug":"api-magentlab-com-api-calc-promise-0eae4f","canonical_url":"https://api.magentlab.com/api/calc/promise","resource":"https://api.magentlab.com/api/calc/promise","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Psallidas 2018 Table 2A clinical PROMISE for malignant pleural effusion: chemo 0/4, radiotherapy 0/2, haemoglobin g/dL 0-4, WBC 10^9/L 0/2/4/7/10, CRP mg/L 0/3/5/8/11, ECOG 0-1=0 or 2-4=7, cancer mesothelioma 0 / other 4 / lung 5. Groups A 0-20 <25%, B 21-27, C 28-35, D >35 >=75% 3-month mortality. Not TIMP1. Not a treatment order.","service_name":"magent","declared_category":null,"declared_tags":["promise","pleural","respiratory","prognosis","calculator"],"route_template":null,"registry_updated":"2026-09-28T13:47:07.756Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc promise","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-01T05:50:06.230Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-01T05:50:06.230Z","calls_30d":2,"unique_payers_30d":1,"last_called_at":"2026-09-28T13:47:07.637Z"},"validation":{"latest":{"observed_at":"2026-10-01T06:28:46.556Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-01"},"uptime":[{"days":7,"observed":5,"passed":5,"ratio":1},{"days":30,"observed":5,"passed":5,"ratio":1},{"days":90,"observed":5,"passed":5,"ratio":1}],"history_90d":[{"observed_at":"2026-10-01T06:28:46.556Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T05:46:32.802Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T18:07:18.944Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:52:30.175Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T14:20:47.845Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["promise","pleural","respiratory","prognosis","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/promise","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T13:47:07.637Z","l30DaysTotalCalls":2,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/promise","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"wbc":8,"ecog":0,"crp_mg_l":20,"cancer_type":"other","chemotherapy":false,"radiotherapy":false,"haemoglobin_g_dl":15},{"wbc":8,"ecog":0,"crp_mg_l":20,"cancer_type":"other","chemotherapy":false,"radiotherapy":false,"haemoglobin_g_dl":15}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/promise","count":2,"items":[{"wbc":8,"ecog":0,"group":"A","score":14,"formula":"promise","citation":{"id":"psallidas-2018","doi":"10.1016/S1470-2045(18)30294-8","pmid":"29908990","title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis","source":"Lancet Oncol. 2018;19(7):930-939","authors":"Psallidas I, Kanellakis NI, Gerry S, et al."},"crp_mg_l":20,"max_score":43,"components":[{"value":false,"factor":"chemotherapy","points":0,"present":false},{"value":false,"factor":"radiotherapy","points":0,"present":false},{"value":15,"factor":"haemoglobin","points":1,"present":true},{"value":8,"factor":"wbc","points":4,"present":true},{"value":20,"factor":"crp","points":5,"present":true},{"value":0,"factor":"ecog","points":0,"present":false},{"value":"other","factor":"cancer_type","points":4,"present":true}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","cancer_type":"other","chemotherapy":false,"radiotherapy":false,"haemoglobin_g_dl":15,"formula_expression":"clinical PROMISE = previous_chemotherapy (no 0, yes 4) + previous_radiotherapy (no 0, yes 2) + haemoglobin_g_dl (≥16 → 0; 14 to <16 → 1; 12 to <14 → 2; 10 to <12 → 3; <10 → 4) + wbc_10e9_l (<4 → 0; 4 to <6.3 → 2; 6.3 to <10 → 4; 10 to <15.8 → 7; ≥15.8 → 10) + crp_mg_l (<3 → 0; 3 to <10 → 3; 10 to <32 → 5; 32 to <100 → 8; ≥100 → 11) + ECOG (0–1 → 0; 2–4 → 7) + cancer_type (mesothelioma → 0; other → 4; lung → 5); Psallidas 2018 Table 2A; groups A 0–20 <25% 3-month mortality, B 21–27 25% to <50%, C 28–35 50% to <75%, D >35 ≥75%","three_month_mortality":"<25%"},{"wbc":8,"ecog":0,"group":"A","score":14,"formula":"promise","citation":{"id":"psallidas-2018","doi":"10.1016/S1470-2045(18)30294-8","pmid":"29908990","title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis","source":"Lancet Oncol. 2018;19(7):930-939","authors":"Psallidas I, Kanellakis NI, Gerry S, et al."},"crp_mg_l":20,"max_score":43,"components":[{"value":false,"factor":"chemotherapy","points":0,"present":false},{"value":false,"factor":"radiotherapy","points":0,"present":false},{"value":15,"factor":"haemoglobin","points":1,"present":true},{"value":8,"factor":"wbc","points":4,"present":true},{"value":20,"factor":"crp","points":5,"present":true},{"value":0,"factor":"ecog","points":0,"present":false},{"value":"other","factor":"cancer_type","points":4,"present":true}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","cancer_type":"other","chemotherapy":false,"radiotherapy":false,"haemoglobin_g_dl":15,"formula_expression":"clinical PROMISE = previous_chemotherapy (no 0, yes 4) + previous_radiotherapy (no 0, yes 2) + haemoglobin_g_dl (≥16 → 0; 14 to <16 → 1; 12 to <14 → 2; 10 to <12 → 3; <10 → 4) + wbc_10e9_l (<4 → 0; 4 to <6.3 → 2; 6.3 to <10 → 4; 10 to <15.8 → 7; ≥15.8 → 10) + crp_mg_l (<3 → 0; 3 to <10 → 3; 10 to <32 → 5; 32 to <100 → 8; ≥100 → 11) + ECOG (0–1 → 0; 2–4 → 7) + cancer_type (mesothelioma → 0; other → 4; lung → 5); Psallidas 2018 Table 2A; groups A 0–20 <25% 3-month mortality, B 21–27 25% to <50%, C 28–35 50% to <75%, D >35 ≥75%","three_month_mortality":"<25%"}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["chemotherapy","radiotherapy","haemoglobin_g_dl","wbc","crp_mg_l","ecog","cancer_type"],"properties":{"wbc":{"type":"number","description":"Serum white cell count as 10^9/L (0.1-80). Psallidas 2018 Table 2A: <4 scores 0; 4 to <6.3 scores 2; 6.3 to <10 scores 4; 10 to <15.8 scores 7; ≥15.8 scores 10. Caller-supplied; magent does not assay WBC."},"ecog":{"type":"integer","description":"Oken 1982 ECOG performance status 0-4 as assigned by the caller. Psallidas 2018 Table 2A: 0-1 scores 0; 2-4 scores 7. Grade 5 (dead) is not scored. magent does not observe the patient or convert Karnofsky."},"crp_mg_l":{"type":"number","description":"Serum CRP in mg/L (0-500), not IU/L. Psallidas 2018 Table 2A: <3 scores 0; 3 to <10 scores 3; 10 to <32 scores 5; 32 to <100 scores 8; ≥100 scores 11. Caller-supplied; magent does not assay CRP or convert IU/L."},"cancer_type":{"enum":["mesothelioma","lung","other"],"type":"string","description":"Psallidas 2018 Table 2A cancer type as assigned by the caller. mesothelioma scores 0; other scores 4; lung scores 5. magent does not assign cancer type from histology text."},"chemotherapy":{"type":"boolean","description":"Previous chemotherapy as assigned by the caller (Psallidas 2018 Table 2A). true or false. true scores 4; false scores 0. Not a chemotherapy order. magent does not read a treatment history."},"radiotherapy":{"type":"boolean","description":"Previous radiotherapy as assigned by the caller (Psallidas 2018 Table 2A). true or false. true scores 2; false scores 0. Not a radiotherapy order. magent does not read a treatment history."},"haemoglobin_g_dl":{"type":"number","description":"Haemoglobin in g/dL (3-25). Psallidas 2018 Table 2A: ≥16 scores 0; 14 to <16 scores 1; 12 to <14 scores 2; 10 to <12 scores 3; <10 scores 4. Caller-supplied; magent does not assay haemoglobin."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Psallidas 2018 Table 2A clinical PROMISE for malignant pleural effusion: chemo 0/4, radiotherapy 0/2, haemoglobin g/dL 0-4, WBC 10^9/L 0/2/4/7/10, CRP mg/L 0/3/5/8/11, ECOG 0-1=0 or 2-4=7, cancer mesothelioma 0 / other 4 / lung 5. Groups A 0-20 <25%, B 21-27, C 28-35, D >35 >=75% 3-month mortality. Not TIMP1. Not a treatment order.","lastUpdated":"2026-09-28T13:47:07.756Z","serviceName":"magent","x402Version":2}]}}